Particle.news
Download on the App Store
18 ARTICLES
·
last wk.

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

The collaboration offers branded Wegovy at reduced cash prices through Hims & Hers, Ro, and LifeMD as compounding pharmacies face legal restrictions.

Image
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. REUTERS/Hollie Adams

Overview

  • Novo Nordisk announced partnerships with Hims & Hers, Ro, and LifeMD to distribute its weight-loss drug Wegovy through telehealth platforms starting this week.
  • The drug will be available at $499 per month via NovoCare and Ro, while Hims & Hers bundles it with membership services for $599 per month.
  • Humana’s CenterWell Pharmacy will fulfill and ship Wegovy prescriptions made through the telehealth platforms as part of the partnership.
  • This move follows regulatory rulings ending FDA-declared shortages and restricting the mass compounding of semaglutide, redirecting demand to branded supply.
  • Shares of Hims & Hers surged nearly 30% on the news, reflecting investor confidence in telehealth-driven distribution models for GLP-1 medications.